Compass Therapeutics CMPX
NASDAQ CMPX
$0.80 -0.01 (-1.23%)
At close: Oct 22, 2026 · 4:00 PM EDT

Compass Therapeutics (CMPX) Cash & Current Investments (2018 - 2026)

Updated

Compass Therapeutics' Cash & Current Investments came in at $180.45 million for Q2 2026, up 77.8% from $101.52 million a year earlier but down 7.6% from the prior quarter.

Analysis

Compass Therapeutics (CMPX) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Compass Therapeutics' Cash & Current Investments was $209.47 million, up 64.6% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of 34.8% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $127.29 million in FY2024 (-16.5%), $152.46 million in FY2023 (-18.3%), $186.61 million in FY2022 (+29.1%) and $144.51 million in FY2021 (+207.0%).
  • The five-year range for quarterly Cash & Current Investments is $25.51 million (Q3 2021) to $220.46 million (Q3 2025).
  • Year-over-year, Cash & Current Investments has increased for four consecutive quarters, with growth averaging 22.2% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q3 2022 (growth of 372.8%), and the weakest in Q1 2025 (a decline of 35.7%).
  • Business Quant data shows CMPX's Cash & Current Investments at $195.26 million (Q1 2026), $209.47 million (Q4 2025) and $220.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 17.23 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 6.57 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 4.90 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 3.18 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 11.70 Bn
10 Compass Therapeutics 144.07 Mn -661.57 Mn - 180.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 180.45 Mn
Mar 31, 2026 195.26 Mn
Dec 31, 2025 209.47 Mn
Sep 30, 2025 220.46 Mn
Jun 30, 2025 101.52 Mn
Mar 31, 2025 113.20 Mn
Dec 31, 2024 127.29 Mn
Sep 30, 2024 135.97 Mn
Jun 30, 2024 146.23 Mn
Mar 31, 2024 176.06 Mn
Dec 31, 2023 152.46 Mn
Sep 30, 2023 163.70 Mn
Jun 30, 2023 168.75 Mn
Mar 31, 2023 175.17 Mn
Dec 31, 2022 186.61 Mn
Sep 30, 2022 120.60 Mn
Jun 30, 2022 132.02 Mn
Mar 31, 2022 136.40 Mn
Dec 31, 2021 144.51 Mn
Sep 30, 2021 25.51 Mn
API Access

Compass Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CMPX&period=max&api_key=YOUR_API_KEY